454 results on '"Scheibenbogen, Carmen"'
Search Results
2. Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exertional Malaise: A Best Practice Proposal
3. Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial
4. Interdisziplinäres, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom
5. Post-COVID und Diabetes mellitus: Bidirektionale Aspekte zweier Pandemien an der Schnittstelle zwischen übertragbarer und nichtübertragbarer Krankheit
6. Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ)
7. Graded exercise therapy should not be recommended for patients with post-exertional malaise
8. Clinical and immunological characterisation of patients with common variable immunodeficiency related immune thrombocytopenia
9. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
10. Correction: Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
11. Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination
12. Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center
13. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
14. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
15. Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis
16. Structural brain changes in patients with post-COVID fatigue: a prospective observational study
17. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
18. Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom
19. Die Übersicht zur aktuellen Evidenz ignoriert die aktuelle Evidenz
20. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study
21. Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
22. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
23. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
24. Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
25. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
26. Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
27. A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms.
28. The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression data
29. Joining European Scientific Forces to Face Pandemics
30. Antibody-mediated autoimmunity in symptom-based disorders: position statement and proceedings from an international workshop.
31. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy
32. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
33. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
34. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
35. Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
36. One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus.
37. Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.
38. Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients.
39. Interstitial Lung Disease Frequently Precedes CVID Diagnosis
40. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study
41. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency
42. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
43. Altered B-cell subsets and functional B-cell defects in selective IgM deficiency
44. Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report.
45. Fatigue bei Erwachsenen, Jugendlichen und Kindern - eine klinische Einordnung im pandemischen Kontext.
46. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
47. Apoptosis Susceptibility Prolongs the Lack of Memory B Cells in Acute Leukemic Patients After Allogeneic Hematopoietic Stem Cell Transplantation
48. Classification of common variable immunodeficiencies using flow cytometry and a memory B-cell functionality assay
49. Serum Free Light Chains in CVID—a Marker for Differential Diagnosis
50. Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.